ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/003/SRR5712393/SRR5712393.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/000/SRR5712380/SRR5712380.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/008/SRR5712408/SRR5712408.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/007/SRR5712387/SRR5712387.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/004/SRR5712384/SRR5712384.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/007/SRR5712397/SRR5712397.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/000/SRR5712370/SRR5712370.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/008/SRR5712378/SRR5712378.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/005/SRR5712405/SRR5712405.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/007/SRR5712377/SRR5712377.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/007/SRR5712407/SRR5712407.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/009/SRR5712399/SRR5712399.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/003/SRR5712383/SRR5712383.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/000/SRR5712390/SRR5712390.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/001/SRR5712371/SRR5712371.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/008/SRR5712368/SRR5712368.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/004/SRR5712404/SRR5712404.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/004/SRR5712374/SRR5712374.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/006/SRR5712396/SRR5712396.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/001/SRR5712401/SRR5712401.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/009/SRR5712389/SRR5712389.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/006/SRR5712376/SRR5712376.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/001/SRR5712391/SRR5712391.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/005/SRR5712395/SRR5712395.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/002/SRR5712382/SRR5712382.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/003/SRR5712403/SRR5712403.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/006/SRR5712386/SRR5712386.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/001/SRR5712381/SRR5712381.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/003/SRR5712373/SRR5712373.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/002/SRR5712392/SRR5712392.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/009/SRR5712409/SRR5712409.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/000/SRR5712400/SRR5712400.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/005/SRR5712375/SRR5712375.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/008/SRR5712388/SRR5712388.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/002/SRR5712402/SRR5712402.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/009/SRR5712369/SRR5712369.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/004/SRR5712394/SRR5712394.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/008/SRR5712398/SRR5712398.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/002/SRR5712372/SRR5712372.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/006/SRR5712406/SRR5712406.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/009/SRR5712379/SRR5712379.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR571/005/SRR5712385/SRR5712385.fastq.gzprimary200OKGenomicsDepartment of Plant and Microbial Biology, University of Minnesota, Twin Citieshttps://www.ebi.ac.uk/ena/browser/view/PRJNA390966Arabidopsis thalianaxref:PubMed:29076543We observed that mutations in CBP60a, CML46, CML47 and WRKY70 enhanced plant resistance to Pma likely through different mechanisms. To investigate their contributions to enhanced resistance at the transcriptome level, we designed this experiment to measure their response to Pma using the SMART-3Seq method. Overall design: Mature leaves of Arabidopsis plants of seven different genotypes were infiltrated with mock or Pma. Samples were collected 24 hours after treatment. Each experiment contains one sample consisted of two leaves for each genotype-treatment combination. In total three independent experiments were conducted.ENAMyelogenous Leukemias, Myelocytic, Networks, CLL, Chronic Myelocytic Leukemia, Chronic Granulocytic Leukemia, Materials, Phosphodiesterase Activator, Family Member, Kinship, CALML2, Philadelphia Positive, Calcium Dependent, Chronic Myeloid Leukemia, Transcriptome Profile, Myeloid, Calcium-Dependent Activator Protein, Myelocytic Leukemia, Gene Expression Profile, Gene, Cyclic AMP-Phosphodiesterase Activator, CAMIII, Profiles, chronic granulocytic leukaemia, Network, protein, Phosphodiesterase Activating Factor, Calcium Dependent Regulator, Philadelphia-Positive Myeloid Leukemias, protein-containing complex, CML, Calcium Dependent Activator Protein, protein polypeptide chains, chronic myelogenous, polypeptide chain, Gene Products, Life Cycle, Ph1 Positive, atypical, Philadelphia-Positive Myeloid Leukemia, Protein Activator, protein aggregate, Family Life Cycle, Bovine Activator Protein, BCR1, Chronic Myelocytic Leukemias, Cyclic AMP Phosphodiesterase Activator, Chronic Granulocytic Leukemias, chronic myeloid, Leukemia, Kinship Network, Genetic, Research, D22S11, Pseudomonas syringae subsp. syringae., Profile, ligand, Granulocytic Leukemia, Cyclic AMP-Phosphodiesterase, Chronic Myelogenous Leukemias, Activator, Myelogenous Leukemia, PHL, proteins, Activating Factor, Signatures, adult chronic leukaemia, Phosphodiesterase Protein, Granulocytic, Bovine, Expression Signature, Ph1-Positive Myelogenous Leukemias, CAMC, Myeloid Leukemia, Myelocytic Leukemias, Transcriptomes, adult chronic leukemia, Ph1-Positive Myeloid Leukemia, Calcium-Dependent Activator, Chronic, Kinship Networks, Family Life Cycles, Family, ALL, Myelogenous, leukemia, Transcriptome, Granulocytic Leukemias, Family Research, protein complex, Chronic Myelocytic, Expression Profiles, Proteins, Ph1-Positive Myelogenous Leukemia, Calcium-Dependent Regulator, Factor, Philadelphia-Positive, Cistrons, Leukemias, chronic, whole transcriptome, Family Members, Gene Expression, Ph1-Positive, D22S662, Ph1-Positive Myeloid Leukemias, Chronic myelogenous leukemia, native protein, chronic myelogenous leukemia, natural protein, Expression Signatures, Philadelphia-Positive Myeloid, Gene Expression Signatures, Protein, Myeloid Leukemias, Activator Protein, Genetic Materials, Gene Expression Signature, Bovine Activator, Filiation, Expression Profile, Phosphodiesterase Activating, Genetic Material, Transcriptome Profiles, Xcml, Chronic granulocytic leukemia, Chronic Granulocytic, Chronic Myelogenous, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemias, Regulator, cml-A, Ph1-Positive Myelogenous, Ph1-Positive Myeloid, Phosphodiesterase, Protein Gene Products, Life Cycles, Gene Proteins, Calcium-Dependent, chronic granulocytic leukemia, Phosphodiesterase Protein Activator, Material, Gene Expression Profiles, Families, chronic myelogenous leukaemia, CML - chronic Myelogenous Leukemia, chronic myeloid leukaemia, AMP-Phosphodiesterase Activator, Cistron, Phosphodiesterase Activator Protein, Cyclic, Signature, Relatives, Chronic Myeloidthale cress, mouse-ear cress, thale-cress, Arabidopsis thalianas, Arbisopsis thaliana, Cresses, A., A. thalianas, thalianas, Arabidopsis thaliana, Mouse-ear Cress, Arabidopsis thaliana (thale cress), Arabidopsis., Cress, thaliana, Mouse ear, A. thaliana, Arabidopses, Mouse-ear Cresses, Mouse-ear, Arabis thalianafalseArabidopsis thalianaTranscriptome profiling of mutants of CALMODULIN-LIKE (CML) family genes and CALMODULIN-BINDING PROTEIN 60 (CBP60) family genes in response to Pseudomonas syringae pv maculicola ES43262025-09-242017-09-19PRJNA390966GSE100187370229076543